Close Menu

NEW YORK (GenomeWeb) – Premaitha Health said today that the Brazilian Health Regulatory Agency (ANVISA) has approved its Iona noninvasive prenatal test as an in vitro diagnostic.

Last September, the agency had already granted the Iona test Brazilian Good Manufacturing Practice (B-GMP) approval, a requirement to register it with ANVISA.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.